Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT for Recurrent Prostate Cancer After Radiation
NCT03253744Phase 1Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2018
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial in prostate cancer (PCa), sponsored by National Cancer Institute. Started Jul 2018; status: completed.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03253744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03253744.